Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

March 01, 2007; Volume 35,Issue 3

Short Communications

  • You have access
    Classification of Metabolites with Kernel-Partial Least Squares (K-PLS)
    Mark J. Embrechts and Sean Ekins
    Drug Metabolism and Disposition March 2007, 35 (3) 325-327; DOI: https://doi.org/10.1124/dmd.106.013185
  • You have access
    Effect of Genetic Variants of the Human Flavin-Containing Monooxygenase 3 on N- and S-Oxygenation Activities
    Makiko Shimizu, Hiroshi Yano, Satomi Nagashima, Norie Murayama, Jun Zhang, John R. Cashman and Hiroshi Yamazaki
    Drug Metabolism and Disposition March 2007, 35 (3) 328-330; DOI: https://doi.org/10.1124/dmd.106.013094
  • You have access
    Inhibitory Effects of Benzoate on Chiral Inversion and Clearance of NG-Nitro-Arginine in Conscious Rats
    Xin Yan-Fei, Zhou Xiang-Jun, Lu Jie and Wang Yong-Xiang
    Drug Metabolism and Disposition March 2007, 35 (3) 331-334; DOI: https://doi.org/10.1124/dmd.106.011429
  • You have access
    CYP2A13 Metabolizes the Substrates of Human CYP1A2, Phenacetin, and Theophylline
    Tatsuki Fukami, Miki Nakajima, Haruko Sakai, Miki Katoh and Tsuyoshi Yokoi
    Drug Metabolism and Disposition March 2007, 35 (3) 335-339; DOI: https://doi.org/10.1124/dmd.106.011064
  • You have access
    Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by Nucleoside, Nucleotide, and Non-Nucleoside Reverse Transcriptase Inhibitors
    Johanna Weiss, Dirk Theile, Nahal Ketabi-Kiyanvash, Heike Lindenmaier and Walter Emil Haefeli
    Drug Metabolism and Disposition March 2007, 35 (3) 340-344; DOI: https://doi.org/10.1124/dmd.106.012765
  • You have access
    In Vitro and in Vivo Determination of Piperacillin Metabolism in Humans
    Giulia Ghibellini, Arlene S. Bridges, Claudia N. Generaux and Kim L. R. Brouwer
    Drug Metabolism and Disposition March 2007, 35 (3) 345-349; DOI: https://doi.org/10.1124/dmd.106.012278

Articles

  • You have access
    Metabolism of Sirolimus in the Presence or Absence of Cyclosporine by Genotyped Human Liver Microsomes and Recombinant Cytochromes P450 3A4 and 3A5
    Nicolas Picard, Nassim Djebli, François-Ludovic Sauvage and Pierre Marquet
    Drug Metabolism and Disposition March 2007, 35 (3) 350-355; DOI: https://doi.org/10.1124/dmd.106.012161
  • You have access
    Functional Expression of Stereoselective Metabolism of Cephalexin by Exogenous Transfection of Oligopeptide Transporter PEPT1
    Keisuke Mitsuoka, Yukio Kato, Yoshiyuki Kubo and Akira Tsuji
    Drug Metabolism and Disposition March 2007, 35 (3) 356-362; DOI: https://doi.org/10.1124/dmd.106.010405
  • You have access
    The Glucuronidation of Δ4-3-Keto C19- and C21-Hydroxysteroids by Human Liver Microsomal and Recombinant UDP-glucuronosyltransferases (UGTs): 6α- and 21-Hydroxyprogesterone Are Selective Substrates for UGT2B7
    K. Bowalgaha, D. J. Elliot, P. I. Mackenzie, K. M. Knights and J. O. Miners
    Drug Metabolism and Disposition March 2007, 35 (3) 363-370; DOI: https://doi.org/10.1124/dmd.106.013052
  • You have access
    UDP-Glucuronosyltransferase 1A1 Is the Principal Enzyme Responsible for Etoposide Glucuronidation in Human Liver and Intestinal Microsomes: Structural Characterization of Phenolic and Alcoholic Glucuronides of Etoposide and Estimation of Enzyme Kinetics
    Zhiming Wen, Melanie N. Tallman, Shazia Y. Ali and Philip C. Smith
    Drug Metabolism and Disposition March 2007, 35 (3) 371-380; DOI: https://doi.org/10.1124/dmd.106.012732
  • You have access
    The Development of a Cocktail CYP2B6, CYP2C8, and CYP3A5 Inhibition Assay and a Preliminary Assessment of Utility in a Drug Discovery Setting
    Charles J. O'Donnell, Ken Grime, Paul Courtney, Dean Slee and Robert J. Riley
    Drug Metabolism and Disposition March 2007, 35 (3) 381-385; DOI: https://doi.org/10.1124/dmd.106.012344
  • You have access
    Constitutive and 3-Methylcholanthrene-Induced Rat ALDH3A1 Expression Is Mediated by Multiple Xenobiotic Response Elements
    Richard Reisdorph and Ronald Lindahl
    Drug Metabolism and Disposition March 2007, 35 (3) 386-393; DOI: https://doi.org/10.1124/dmd.106.012393
  • You have access
    Mechanism of the Regulation of Organic Cation/Carnitine Transporter 1 (SLC22A4) by Rheumatoid Arthritis-Associated Transcriptional Factor RUNX1 and Inflammatory Cytokines
    Tomoji Maeda, Masamichi Hirayama, Daisuke Kobayashi, Keiji Miyazawa and Ikumi Tamai
    Drug Metabolism and Disposition March 2007, 35 (3) 394-401; DOI: https://doi.org/10.1124/dmd.106.012112
  • You have access
    Differential Regulation of Hepatic Transporters in the Absence of Tumor Necrosis Factor-α, Interleukin-1β, Interleukin-6, and Nuclear Factor-κB in Two Models of Cholestasis
    Andrew J. Lickteig, Angela L. Slitt, Melek C. Arkan, Michael Karin and Nathan J. Cherrington
    Drug Metabolism and Disposition March 2007, 35 (3) 402-409; DOI: https://doi.org/10.1124/dmd.106.012138
  • You have access
    Effect of Oral Ketoconazole on Intestinal First-Pass Effect of Midazolam and Fexofenadine in Cynomolgus Monkeys
    Akihito Ogasawara, Toshiyuki Kume and Emiko Kazama
    Drug Metabolism and Disposition March 2007, 35 (3) 410-418; DOI: https://doi.org/10.1124/dmd.106.011288
  • You have access
    Expression of the Human UGT1 Locus in Transgenic Mice by 4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic Acid (WY-14643) and Implications on Drug Metabolism through Peroxisome Proliferator-Activated Receptor α Activation
    Kathy Senekeo-Effenberger, Shujuan Chen, Erin Brace-Sinnokrak, Jessica A. Bonzo, Mei-Fei Yueh, Upendra Argikar, Jenny Kaeding, Jocelyn Trottier, Rory P. Remmel, Joseph K. Ritter, Olivier Barbier and Robert H. Tukey
    Drug Metabolism and Disposition March 2007, 35 (3) 419-427; DOI: https://doi.org/10.1124/dmd.106.013243
  • You have access
    CAR2 Displays Unique Ligand Binding and RXRα Heterodimerization Characteristics
    Scott S. Auerbach, Joshua G. DeKeyser, Matthew A. Stoner and Curtis J. Omiecinski
    Drug Metabolism and Disposition March 2007, 35 (3) 428-439; DOI: https://doi.org/10.1124/dmd.106.012641
  • You have access
    Glucuronidation of Anti-HIV Drug Candidate Bevirimat: Identification of Human UDP-glucuronosyltransferases and Species Differences
    Zhiming Wen, David E. Martin, Peter Bullock, Kuo-Hsiung Lee and Philip C. Smith
    Drug Metabolism and Disposition March 2007, 35 (3) 440-448; DOI: https://doi.org/10.1124/dmd.106.012815
  • You have access
    Gender-Related Differences in Mycophenolate Mofetil-Induced Gastrointestinal Toxicity in Rats
    Stephan T. Stern, Melanie N. Tallman, Kristini K. Miles, Joseph K. Ritter, Robert E. Dupuis and Philip C. Smith
    Drug Metabolism and Disposition March 2007, 35 (3) 449-454; DOI: https://doi.org/10.1124/dmd.106.012013
  • You have access
    Pharmacokinetics and Pharmacodynamics of Alfentanil in P-Glycoprotein-Competent and P-Glycoprotein-Deficient Mice: P-Glycoprotein Efflux Alters Alfentanil Brain Disposition and Antinociception
    J. Cory Kalvass, Emily R. Olson and Gary M. Pollack
    Drug Metabolism and Disposition March 2007, 35 (3) 455-459; DOI: https://doi.org/10.1124/dmd.106.011445
  • You have access
    Cross-Species Pharmacokinetic Comparison from Mouse to Man of a Second-Generation Antisense Oligonucleotide, ISIS 301012, Targeting Human Apolipoprotein B-100
    Rosie Z. Yu, Tae-Won Kim, An Hong, Tanya A. Watanabe, Hans J. Gaus and Richard S. Geary
    Drug Metabolism and Disposition March 2007, 35 (3) 460-468; DOI: https://doi.org/10.1124/dmd.106.012401
  • You have access
    Characterization of the Hepatic Disposition of Lanoteplase, a Rationally Designed Variant of Tissue Plasminogen Activator in Rodents
    Kazumi Komoriya, Yukio Kato, Yujiro Hayashi, Kazuhiro Ohsuye, Ryuichiro Nishigaki and Yuichi Sugiyama
    Drug Metabolism and Disposition March 2007, 35 (3) 469-475; DOI: https://doi.org/10.1124/dmd.106.012518
  • You have access
    Involvement of CYP2A6 in the Formation of a Novel Metabolite, 3-Hydroxypilocarpine, from Pilocarpine in Human Liver Microsomes
    Takuro Endo, Masaaki Ban, Kazuma Hirata, Akitoshi Yamamoto, Yoshiki Hara and Yasunori Momose
    Drug Metabolism and Disposition March 2007, 35 (3) 476-483; DOI: https://doi.org/10.1124/dmd.106.013425
  • You have access
    Helices F–G Are Important for the Substrate Specificities of CYP3A7
    Nao Torimoto, Itsuko Ishii, Ken-Ichi Toyama, Masayuki Hata, Kanako Tanaka, Hitoshi Shimomura, Hiroyoshi Nakamura, Noritaka Ariyoshi, Shigeru Ohmori and Mitsukazu Kitada
    Drug Metabolism and Disposition March 2007, 35 (3) 484-492; DOI: https://doi.org/10.1124/dmd.106.011304
  • You have access
    Three-Dimensional Quantitative Structure-Activity Relationship Analysis of Human CYP51 Inhibitors
    Sean Ekins, Dayna C. Mankowski, Dennis J. Hoover, Michael P. Lawton, Judith L. Treadway and H. James Harwood
    Drug Metabolism and Disposition March 2007, 35 (3) 493-500; DOI: https://doi.org/10.1124/dmd.106.013888

Letter to the Editor

  • You have access
    Misuse of the Well-Stirred Model of Hepatic Drug Clearance
    Jiansong Yang, Masoud Jamei, Karen R. Yeo, Amin Rostami-Hodjegan and Geoffrey T. Tucker
    Drug Metabolism and Disposition March 2007, 35 (3) 501-502; DOI: https://doi.org/10.1124/dmd.106.013359
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 35 (3)
Drug Metabolism and Disposition
Vol. 35, Issue 3
1 Mar 2007
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Short Communications
  • Articles
  • Letter to the Editor
  • Most Read
Loading
  • Cannabinoid Metabolites as CYP450 Inhibitors
  • Physiology of the Neonatal Gastrointestinal System
  • Pharmacokinetics and Disposition of Biologics
  • Alternative P450 Splicing Redirects Human Drug Metabolism
  • Switch from CAR to PXR in the Presence of EGF
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics